Allergy Therapeutics PLC hails conclusion of 'breakthrough' hay fever field study
Results are due in the second half and will be used to design the company's phase III trial of Grass MATA MPL
Source: proactiveinvestors.co.uk
Stay updated with breaking news from Lon Agy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results are due in the second half and will be used to design the company's phase III trial of Grass MATA MPL